EP 3518965 A1 20190807 - MULTIVALENT PNEUMOCOCCAL VACCINE COMPOSITIONS COMPRISING POLYSACCHARIDE-PROTEIN CONJUGATES
Title (en)
MULTIVALENT PNEUMOCOCCAL VACCINE COMPOSITIONS COMPRISING POLYSACCHARIDE-PROTEIN CONJUGATES
Title (de)
MEHRWERTIGE PNEUMOKOKKEN-IMPFSTOFFZUSAMMENSETZUNGEN MIT POLYSACCHARIDPROTEINKONJUGATEN
Title (fr)
COMPOSITIONS DE VACCIN ANTIPNEUMOCOCCIQUE MULTIVALENT COMPRENANT DES CONJUGUÉS POLYSACCHARIDE-PROTÉINE
Publication
Application
Priority
- IN 201641033563 A 20160930
- US 2017054237 W 20170929
Abstract (en)
[origin: WO2018064444A1] The present disclosure relates to multivalent pneumococcal vaccine compositions comprising capsular pneumococcal polysaccharide serotypes each individually conjugated to carrier proteins. When conjugated, the combination of the capsular pneumococcal polysaccharide serotype and the carrier protein is referred to herein as a polysaccharide-protein conjugate. The pneumococcal vaccine compositions may further comprise one or more of the following; a pharmaceutically acceptable carrier, a pharmaceutically acceptable diluent, a buffer, a preservative, a stabilizer, an adjuvant, and/or a lyophilization excipient. Methods of making and administering the pneumococcal vaccine compositions described herein are also provided.
IPC 8 full level
A61K 39/09 (2006.01); A61K 39/00 (2006.01); A61K 39/385 (2006.01); A61K 39/39 (2006.01); A61P 31/04 (2006.01)
CPC (source: EP IL KR US)
A61K 9/0019 (2013.01 - IL US); A61K 39/092 (2013.01 - EP IL KR US); A61K 39/385 (2013.01 - EP IL KR US); A61K 39/39 (2013.01 - EP IL US); A61P 11/00 (2018.01 - EP IL); A61P 25/00 (2018.01 - EP IL); A61P 27/16 (2018.01 - EP IL); A61P 29/00 (2018.01 - EP IL); A61P 31/04 (2018.01 - EP IL KR); A61P 37/04 (2018.01 - EP IL); A61K 2039/55505 (2013.01 - EP IL KR US); A61K 2039/6068 (2013.01 - EP IL KR US); A61K 2039/70 (2013.01 - EP IL US)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2018064444 A1 20180405; AU 2017336806 A1 20190502; AU 2017336806 A8 20190516; AU 2017336806 B2 20240627; BR 112019006278 A2 20190702; CA 3037056 A1 20180405; CL 2019000849 A1 20190923; CN 109789198 A 20190521; CO 2019002955 A2 20190611; CU 20190030 A7 20191104; CU 24660 B1 20230511; EA 201990838 A1 20190830; EP 3518965 A1 20190807; IL 265623 A 20190530; IL 265623 B 20221201; IL 265623 B2 20230401; IL 297575 A 20221201; IL 297575 B1 20230801; IL 297575 B2 20231201; JP 2019529497 A 20191017; JP 2022105155 A 20220712; JP 7403576 B2 20231222; KR 102608081 B1 20231129; KR 20190066032 A 20190612; MX 2019003593 A 20190610; NZ 752348 A 20221125; PH 12019500672 A1 20190729; SA 519401317 B1 20231114; UA 126385 C2 20220928; US 11547752 B2 20230110; US 2019224295 A1 20190725
DOCDB simple family (application)
US 2017054237 W 20170929; AU 2017336806 A 20170929; BR 112019006278 A 20170929; CA 3037056 A 20170929; CL 2019000849 A 20190329; CN 201780060834 A 20170929; CO 2019002955 A 20190327; CU 20190030 A 20170929; EA 201990838 A 20170929; EP 17784755 A 20170929; IL 26562319 A 20190326; IL 29757522 A 20221024; JP 2019517383 A 20170929; JP 2022076109 A 20220502; KR 20197012456 A 20170929; MX 2019003593 A 20170929; NZ 75234817 A 20170929; PH 12019500672 A 20190328; SA 519401317 A 20190314; UA A201904547 A 20170929; US 201916369933 A 20190329